Literature DB >> 23656775

Cellular immortalization and neoplastic transformation: Simultaneous, sequential or independent? Telomeres, telomerase or karyotypic variations?

Chiara Mondello1, Ilaria Chiodi.   

Abstract

Keywords:  cancer; cellular transformation; chromosomal aberration; karyotype; microarray; oncogene; telomerase; telomere; transcription profiling; tumorsuppressor gene

Mesh：

Year:  2013        PMID： 23656775      PMCID： PMC3713139          DOI： 10.4161/cc.24940

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals.

Authors:  Chiara Mondello; Massimo Chiesa; Paola Rebuzzini; Samantha Zongaro; Annalisa Verri; Tina Colombo; Elena Giulotto; Maurizio D'Incalci; Claudio Franceschi; Fiorella Nuzzo
Journal:  Biochem Biophys Res Commun       Date:  2003-09-05       Impact factor: 3.575

2.  Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.

Authors:  Paola Ostano; Silvia Bione; Cristina Belgiovine; Ilaria Chiodi; Chiara Ghimenti; A Ivana Scovassi; Giovanna Chiorino; Chiara Mondello
Journal:  OMICS       Date:  2012 Jan-Feb

Review 3.  Telomere loss: mitotic clock or genetic time bomb?

Authors:  C B Harley
Journal:  Mutat Res       Date:  1991 Mar-Nov       Impact factor: 2.433

Review 4.  Role of telomeres and telomerase in cancer.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Semin Cancer Biol       Date:  2011-10-17       Impact factor: 15.707

5.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

6.  Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.

Authors:  Samantha Zongaro; Elisa de Stanchina; Tina Colombo; Maurizio D'Incalci; Elena Giulotto; Chiara Mondello
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.

Authors:  M A Blasco; H W Lee; M P Hande; E Samper; P M Lansdorp; R A DePinho; C W Greider
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

Review 8.  Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.

Authors:  C Belgiovine; I Chiodi; C Mondello
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

9.  Immortality of cancers: a consequence of inherent karyotypic variations and selections for autonomy.

Authors:  Peter Duesberg; Amanda McCormack
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534
  9 in total
  4 in total

1.  Immortalization of common marmoset monkey fibroblasts by piggyBac transposition of hTERT.

Authors:  Stoyan Petkov; Tobias Kahland; Orr Shomroni; Thomas Lingner; Gabriela Salinas; Sigrid Fuchs; Katharina Debowski; Rüdiger Behr
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

2.  Toxoplasma gondii-induced host cellular cell cycle dysregulation is linked to chromosome missegregation and cytokinesis failure in primary endothelial host cells.

Authors:  Zahady D Velásquez; Iván Conejeros; Camilo Larrazabal; Katharina Kerner; Carlos Hermosilla; Anja Taubert
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

Review 3.  Advancements in MAFLD Modeling with Human Cell and Organoid Models.

Authors:  Shi-Xiang Wang; Ji-Song Yan; Yun-Shen Chan
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

4.  Besnoitia besnoiti-driven endothelial host cell cycle alteration.

Authors:  Zahady D Velásquez; Sara Lopez-Osorio; Learta Pervizaj-Oruqaj; Susanne Herold; Carlos Hermosilla; Anja Taubert
Journal:  Parasitol Res       Date:  2020-06-17       Impact factor: 2.289
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.